Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
09/2000
09/06/2000CN1265671A Alatrofloxacin parenteral compositions
09/06/2000CN1265670A Dipeptide and related compounds which inhibit leukocyte adhesion medicated by VLA-4
09/06/2000CN1265669A Compounds which inhibit leukocyte adhesion mediated by VLA-4
09/06/2000CN1265668A Subtsituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
09/06/2000CN1265667A Method for preparing salt of aspartame from N-protected aspartame
09/06/2000CN1265657A Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
09/06/2000CN1056141C 哌嗪衍生物 Piperazine derivatives
09/05/2000US6114390 An argininamide or ornithinamide compound as treating memory loss, migraine, sleep disorders, pain, cardiovascular diseases, subarachnoidal bleeding, vascular-hypertrophic changes, cerebral and coronary vasospasms
09/05/2000US6114358 Thrombin inhibitors
09/05/2000US6114310 Efflux pump inhibitors
09/05/2000US6114308 Inhibitors of trypsin-like enzymes
09/05/2000US6114132 For determining the binding ability of a ligand to a cysteine-containing wild-type tyrosine phosphatase; medical diagnosis
08/2000
08/31/2000WO2000050447A1 Carbohydrate epitope mimic peptides and uses thereof
08/31/2000WO2000050446A1 Oligopeptide derivatives for the electrochemical measurement of protease activity
08/31/2000CA2363827A1 Oligopeptide derivatives for the electrochemical measurement of protease activity
08/31/2000CA2363601A1 Carbohydrate epitope mimic peptides and uses thereof
08/30/2000EP1031575A1 Process for preparing growth hormone secretagogues
08/30/2000EP1030866A2 Methods and compositions to alter the cell surface expression of phosphatidylserine and other clot-promoting plasma membrane phospholipids
08/30/2000EP1030853A1 Novel signal transduction inhibitors, compositions containing them
08/30/2000EP1030835A2 Urea derivatives and their use as integrin inhibitors
08/30/2000EP1030831A1 Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides
08/30/2000EP0977985A4 Method of determining three-dimensional protein structure from primary protein sequence
08/30/2000EP0765340B1 Methionine sulfone and s-substituted cysteine sulfone derivatives as enzyme inhibitors
08/30/2000EP0584290B1 Endothelin antagonists
08/30/2000CN1265115A Streptogramines, their prepn. and compsns. containing them
08/29/2000US6110932 Increase the level of endogenous growth hormone for the treatment and prevention of osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair, accelerating wound healing
08/29/2000US6110923 Method for treating cancer using novel substituted purinyl derivatives with immunomodulating activity
08/29/2000US6110900 Nucleic acid ligands
08/29/2000US6110896 Peptidyl compounds and their therapeutic use
08/29/2000US6110697 Histone deacetylase as target for antiprotozoal agents
08/24/2000WO2000049037A1 Growth hormone secretagogues
08/24/2000WO2000049036A1 N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER AGGLOMERATE
08/24/2000WO2000049008A1 Di- and tripeptide nitrile derivatives as inhibitors of cathepsin l and cathepsin s
08/24/2000WO2000048623A1 Novel amide derivatives as growth hormone secretagogues
08/24/2000WO2000022112A9 Stabilized bioactive peptides and methods of identification, synthesis and use
08/24/2000WO2000021987A9 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease
08/24/2000WO1998007308A3 Thrombin inhibitors
08/24/2000WO1998000439A3 Multivalent compounds for cross-linking receptors and uses thereof
08/24/2000CA2362303A1 Growth hormone secretagogues
08/24/2000CA2362290A1 Novel amide derivatives as growth hormone secretagogues
08/23/2000EP1029869A1 Endothelin converting enzyme inhibitors
08/23/2000EP1028977A2 Bifidus stimulating peptides
08/23/2000EP1028942A2 Dipeptide nitriles
08/23/2000EP0861228B1 Lipopolyamines as transfection agents and pharmaceutical uses thereof
08/23/2000CN1055700C Therapeutic peptide derivatives
08/23/2000CN1055699C Sulfomycin analogue
08/23/2000CN1055698C Tripeptide antithrombotic agents
08/22/2000US6107494 Substituted 5-aryl-benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
08/22/2000US6107469 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody
08/22/2000US6107410 A photosensitive crosslinked cinnamic acid-spacer-poly-saccharide forming a cyclobutane ring when dimerized; medical material having biocompatibility, bioresorptivity and solubility; films, gels and powders
08/22/2000US6107329 Hypotensive agents; cardiovascular disorders
08/22/2000US6107306 Heterocyclic compounds
08/22/2000US6107293 Analgesics
08/22/2000US6107281 Compounds and their combinations for the treatment of influenza infection
08/22/2000US6107275 Anticoagulants
08/22/2000US6107274 Enzyme inhibitors as hypoglycemic agents in treatment of type-ii diabetes
08/22/2000US6107271 Neuroactive peptides
08/22/2000CA2165992C Disulphides
08/22/2000CA2018801C Antiherpes peptide derivatives having a 1,4-dioxo c n-terminus
08/17/2000WO2000047608A1 Process for the preparation of cyclic tetrapeptide derivatives
08/17/2000WO2000047605A2 Enterocyte growth factors and method for their isolation
08/17/2000WO2000047563A1 LACTAM INHIBITORS OF FXa AND METHOD
08/17/2000WO2000047220A1 Controlling protein levels in eucaryotic organisms
08/17/2000WO2000013026A9 Energy transfer dyes
08/17/2000CA2362560A1 Controlling protein levels in eucaryotic organisms
08/17/2000CA2361919A1 Lactam inhibitors of fxa and method
08/16/2000EP1028126A1 Depsipeptide derivatives bearing piperazinone rings
08/16/2000EP1028125A1 Dipeptide compounds having fungicidal activity and their agronomic use
08/16/2000EP1027056A1 Alpha-ketoamide multicatalytic protease inhibitors
08/16/2000EP1026988A1 Novel fluorescent reporter molecules and their applications including assays for caspases
08/16/2000EP0755374B1 Process for peptide segment condensation
08/16/2000EP0509080B1 Inhibitors and substrates of thrombin
08/15/2000US6103910 D-proline derivatives
08/15/2000US6103870 CS-1 peptidomimetic, compositions and methods of using the same
08/15/2000US6103739 Metalloproteinase inhibitors
08/15/2000US6103720 Ketobenzamides as calpain inhibitors
08/15/2000US6103711 Inhibitors of interleukin-1β converting enzyme
08/15/2000US6103699 Immunosuppressive agent
08/15/2000US6103698 Useful in treating cancer in a mammal; in combination with paclitaxel and taxotere
08/15/2000US6103697 Novel homodimers that include cysteine-containing peptides having 4-15 amino acid residues
08/15/2000US6103692 Administering to said mammal, or contacting said cells with, a compound which inhibits lipid-dependent direct binding of a non-effector loop domain of ras with a raf zinc finger domain
08/10/2000WO2000011020A9 Deoxyhypusine reagent and peptides
08/09/2000EP1025119A1 Histogranin peptide and their analgesic use
08/09/2000EP1025117A1 Novel aspartame crystals and process for the preparation thereof
08/09/2000CN1262275A Substituted thiazol [3,2-alpha] azatropylidene derivatives
08/09/2000CN1262272A HIV proteinase inhibitor
08/08/2000US6100422 Crystallization of alpha-L-aspartyl-L-phenylalanine methyl esther
08/08/2000US6100380 Amino acid sequences; for the treatment of infections, anemias, allergies and immune defects
08/08/2000US6100298 Mixture of drug and n-(4-(carboxypropyl)phenyl-4-phenyl-butyramide for improved oral drug delivery
08/08/2000US6100282 Thiazole derivatives
08/08/2000US6100278 N-(arylsulphonyl)amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
08/08/2000US6100238 Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as serine protease inhibitors
08/08/2000US6099856 Increased bioavailable
08/03/2000WO2000044770A1 Substituted phenethylamine derivatives
08/03/2000WO2000044733A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
08/03/2000WO2000044714A1 S-nitrosothiols as agents for the treatment of circulatory dysfunctions
08/03/2000WO2000044366A2 Therapeutic compositions containing glutathione analogs
08/03/2000WO2000005208A9 Amino-aldehyde solid support, linker therefor and methods of preparation and use thereof
08/03/2000WO1999015130A3 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same
08/03/2000CA2361479A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
1 ... 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 ... 307